Financials Weihai Baihe Biology Technological Co., Ltd.

Equities

603102

CNE100005RB6

Food Processing

End-of-day quote Shanghai S.E. 03:30:00 17/07/2024 am IST 5-day change 1st Jan Change
29.47 CNY -0.20% Intraday chart for Weihai Baihe Biology Technological Co., Ltd. +0.31% -24.01%

Valuation

Fiscal Period: December 2022 2023
Capitalization 1 2,598 2,482
Enterprise Value (EV) 1 1,501 1,348
P/E ratio 18.5 x 14.7 x
Yield 1.48% 1.93%
Capitalization / Revenue 3.58 x 2.85 x
EV / Revenue 2.07 x 1.55 x
EV / EBITDA 8.84 x 6.52 x
EV / FCF 28.7 x 26.8 x
FCF Yield 3.49% 3.73%
Price to Book 1.83 x 1.61 x
Nbr of stocks (in thousands) 64,000 64,000
Reference price 2 40.59 38.78
Announcement Date 06/04/23 11/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 507.5 499.6 578.3 661.9 725.3 871.3
EBITDA 1 87.62 108.6 159.1 176.2 169.8 206.9
EBIT 1 83.62 87.62 137.7 154 138.2 170.9
Operating Margin 16.48% 17.54% 23.8% 23.26% 19.05% 19.61%
Earnings before Tax (EBT) 1 86.43 86.96 148 169.3 158.2 193.4
Net income 1 74.63 74.33 127.1 148 137.8 169.1
Net margin 14.71% 14.88% 21.98% 22.37% 19% 19.4%
EPS 2 1.550 1.550 2.650 3.080 2.200 2.640
Free Cash Flow 1 -10.87 79.36 53.02 14.38 52.33 50.32
FCF margin -2.14% 15.88% 9.17% 2.17% 7.21% 5.78%
FCF Conversion (EBITDA) - 73.1% 33.33% 8.16% 30.82% 24.32%
FCF Conversion (Net income) - 106.76% 41.71% 9.71% 37.96% 29.77%
Dividend per Share - - - 0.5000 0.6000 0.7500
Announcement Date 14/06/19 12/06/20 11/01/22 18/04/22 06/04/23 11/04/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 213 292 385 411 1,097 1,134
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -10.9 79.4 53 14.4 52.3 50.3
ROE (net income / shareholders' equity) 19.5% 17% 24.4% 22.9% 12.9% 11.5%
ROA (Net income/ Total Assets) 9.72% 9.18% 12.8% 11.7% 6.7% 6.29%
Assets 1 767.4 810 995.8 1,264 2,057 2,690
Book Value Per Share 2 8.590 9.640 12.10 14.90 22.20 24.00
Cash Flow per Share 2 4.450 6.090 8.010 8.630 17.20 18.00
Capex 1 45.6 20.2 34 125 51.5 96.5
Capex / Sales 8.99% 4.03% 5.87% 18.82% 7.11% 11.08%
Announcement Date 14/06/19 12/06/20 11/01/22 18/04/22 06/04/23 11/04/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 603102 Stock
  4. Financials Weihai Baihe Biology Technological Co., Ltd.